» Articles » PMID: 17889624

Activation-induced Deaminase, AID, is Catalytically Active As a Monomer on Single-stranded DNA

Overview
Publisher Elsevier
Date 2007 Sep 25
PMID 17889624
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Hypermutation and class switch recombination of immunoglobulin genes are antigen-activated mechanisms triggered by AID, a cytidine deaminase. AID deaminates cytidine residues in the DNA of the variable and the switch regions of the immunoglobulin locus. The resulting uracil induces error-prone DNA synthesis in the case of hypermutation or DNA breaks that activate non-homologous recombination in the case of class switch recombination. In vitro studies have demonstrated that AID deaminates single-stranded but not double-stranded substrates unless AID is in a complex with RPA and the substrate is actively undergoing transcription. However, it is not clear whether AID deaminates its substrates primarily as a monomer or as a higher order oligomer. To examine the oligomerization state of AID alone and in the presence of single-stranded DNA substrates of various structures, including loops embedded in double-stranded DNA, we used atomic force microscopy (AFM) to visualize AID protein alone or in complex with DNA. Surprisingly, AFM results indicate that most AID molecules exist as a monomer and that it binds single-stranded DNA substrates as a monomer at concentrations where efficient deamination of single-stranded DNA substrates occur. The rate of deamination, under conditions of excess and limiting protein, also imply that AID can deaminate single-stranded substrates as a monomer. These results imply that non-phosphorylated AID is catalytically active as a monomer on single-stranded DNA in vitro, including single-stranded DNA found in loops similar to those transiently formed in the immunoglobulin switch regions during transcription.

Citing Articles

Targeted Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases.

Skrekas C, Limeta A, Siewers V, David F ACS Synth Biol. 2023; 12(8):2278-2289.

PMID: 37486333 PMC: 10443040. DOI: 10.1021/acssynbio.2c00690.


Small-Angle X-ray Scattering Models of APOBEC3B Catalytic Domain in a Complex with a Single-Stranded DNA Inhibitor.

Barzak F, Ryan T, Kvach M, Kurup H, Aihara H, Harris R Viruses. 2021; 13(2).

PMID: 33673243 PMC: 7918907. DOI: 10.3390/v13020290.


HPV Meets APOBEC: New Players in Head and Neck Cancer.

Riva G, Albano C, Gugliesi F, Pasquero S, Castillo Pacheco S, Pecorari G Int J Mol Sci. 2021; 22(3).

PMID: 33573337 PMC: 7866819. DOI: 10.3390/ijms22031402.


APOBEC: A molecular driver in cervical cancer pathogenesis.

Revathidevi S, Murugan A, Nakaoka H, Inoue I, Munirajan A Cancer Lett. 2020; 496:104-116.

PMID: 33038491 PMC: 7539941. DOI: 10.1016/j.canlet.2020.10.004.


Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid Ligands.

Salter J, Smith H Trends Biochem Sci. 2018; 43(8):606-622.

PMID: 29803538 PMC: 6073885. DOI: 10.1016/j.tibs.2018.04.013.


References
1.
Phung Q, Winter D, Cranston A, Tarone R, Bohr V, Fishel R . Increased hypermutation at G and C nucleotides in immunoglobulin variable genes from mice deficient in the MSH2 mismatch repair protein. J Exp Med. 1998; 187(11):1745-51. PMC: 2212314. DOI: 10.1084/jem.187.11.1745. View

2.
Manis J, Gu Y, Lansford R, Sonoda E, Ferrini R, Davidson L . Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J Exp Med. 1998; 187(12):2081-9. PMC: 2212369. DOI: 10.1084/jem.187.12.2081. View

3.
Rada C, Ehrenstein M, Neuberger M, Milstein C . Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity. 1998; 9(1):135-41. DOI: 10.1016/s1074-7613(00)80595-6. View

4.
Eisen H, Siskind G . VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE. Biochemistry. 1964; 3:996-1008. DOI: 10.1021/bi00895a027. View

5.
Bransteitter R, Pham P, Calabrese P, Goodman M . Biochemical analysis of hypermutational targeting by wild type and mutant activation-induced cytidine deaminase. J Biol Chem. 2004; 279(49):51612-21. DOI: 10.1074/jbc.M408135200. View